Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tesseract Medical Research is a biotechnology company specializing in the development of high-bioavailability nutraceuticals and medical foods. The company was founded by Al Czap, the former founder of Thorne Research, with a focus on addressing complex chronic conditions through advanced molecular delivery. Tesseract utilizes its proprietary CyLoc and DexKey delivery platforms to encapsulate and release bioactive molecules that are traditionally difficult for the body to absorb. Their product line includes specialized formulations for autism spectrum disorder, gastrointestinal health, and systemic inflammation. By improving the solubility and palatability of these compounds, the company aims to provide more effective therapeutic options for patients and practitioners. Tesseract operates out of Napa, California, and emphasizes a research-driven approach to nutritional science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tesseract Medical Research.